At Pancreatic Cancer Canada Foundation (PCCF), strategic partners help fund innovative pancreatic cancer research through our PancOne™ network and provide support to those living with the disease through our Wellspring patient program.
Our partnership arrangements are designed to be mutually beneficial and drive the organization’s mission forward. For further information, please contact Amy Lewis, Director, Strategic Partnerships at email@example.com
TELUS became engaged after the passing of a beloved executive from pancreatic cancer. Their annual in-store campaign utilizes TELUS and Koodo stores, as well as their nationwide dealer network, to raise funds and awareness about the devastating statistics of this disease. Funds raised are directed to the Joe Goodbaum fund, part of PCCF’s PancOne™ research network.
As one of Google’s charities of choice, PCCF benefits from ‘Google Giving Week’, an employee-driven philanthropic fundraising initiative. PCCF has leveraged Google’s technical prowess to build a microsite for the #AssumptionsCanBeDeadly campaign and is the recipient of a Google grant designed to help enhance the organization’s brand presence online.
PCCF exists to fight this aggressive, deadly form of cancer. To do this, we work with organizations and individuals that share our vision and can help advance our efforts. Included among these are pharmaceutical and biotechnology companies, as they play a pivotal role researching the next generation of treatments and manufacturing therapies currently approved for use in Canada. PCCF works with these companies to:
- Accelerate promising research findings towards the development of new treatments
- Bring attention to the specific issues and needs of pancreatic cancer patients
- Leverage and deploy resources to improve the patient experience
- Increase public understanding of what it means to be diagnosed with pancreatic cancer
Funds received by PCCF from pharmaceutical industry partners are done so as unrestricted educational grants and full transparency is paramount.